Latest news with #CMV
CTV News
19 hours ago
- CTV News
50 charges laid in widespread commercial vehicle enforcement campaign
Numerous charges were laid after a commercial motor vehicle (CMV) enforcement campaign this past week. Numerous violations were issued after several police services led a campaign to enforce commercial motor vehicle (CMV) safety this week in the northwestern outskirts of the Greater Toronto Area. According to a social media post by provincial police, Caledon OPP, York Regional Police, Peel Regional Police, Halton Regional Police, the Town of Caledon, and the Ministry of Transportation teamed up for the campaign this past Thursday. As a result, OPP reported 67 inspections conducted, 50 charges laid, 16 CMV's taken out of service and one driver taken out of service. Police say the Ministry of Finance also supported the campaign by conducting more than 40 inspections relating to the Fuel Tax Act and the Dangerous Goods Transportation Act. According to the province, operators can face fines of up to $20,000 for failing to meet CMV safety standards and requirements.
Time of India
3 days ago
- Time of India
Case booked for reckless driving
Manipal: A case was registered against the driver of a black car for reckless driving and using illegally tinted windows, following a chase by police on Wednesday. It is learnt that inspector Mahesh Prasad of Manipal police station was on patrol duty when he spotted the vehicle near Tiger Circle . The car with fully tinted glass was being driven in a rash manner, posing a risk to fellow motorists. When the officer signalled the driver to stop, the latter continued to drive dangerously. Suspecting that the vehicle might be carrying illegal or unauthorised items, police attempted to follow it. However, the driver sped off and disappeared after taking a sharp left turn at Syndicate Circle near MIT Junction. Upon further inspection, it was found that the car bore a defective number plate. Manipal police registered a case under sections 281 and 125 of Bharatiya Nyaya Sanhita and provisions under CMV and IMV Act.
Time of India
3 days ago
- Time of India
Karnataka police arrested driver for reckless driving, illegal window tint, and faulty number plate
MANIPAL: A case has been registered against the driver of a black car for reckless driving and using illegally tinted windows, following a police chase on Wednesday. Inspector Mahesh Prasad from the Manipal Police Station was on patrol duty when he noticed the vehicle near Tiger Circle. The car was fitted with fully tinted windows and was being driven in a rash manner, endangering two-wheelers and other road users. When the officer signalled the driver to stop, he ignored the warning and continued driving dangerously. Suspecting the vehicle could be carrying illegal or unauthorised items, the police attempted to give chase. However, the driver sped away and vanished after taking a sharp left turn at Syndicate Circle near MIT Junction. Further checks revealed that the vehicle had a faulty number plate. Manipal Police registered a case under Sections 281 and 125 of the Bharatiya Nyaya Sanhita (BNS), along with relevant provisions of the Central Motor Vehicles (CMV) Act and the Indian Motor Vehicles (IMV) Act.
Yahoo
13-06-2025
- Business
- Yahoo
Is it Time to Dump Your Shares of Moderna?
Moderna stock soared early in the pandemic thanks to sales of its coronavirus vaccine. Since then, vaccine demand has declined, and that's weighed on the stock. Even good news from Moderna hasn't lifted the shares for long in recent times. These 10 stocks could mint the next wave of millionaires › After soaring to success in the early days of the COVID-19 pandemic, Moderna (NASDAQ: MRNA) experienced a reversal of fortune. The coronavirus vaccine maker has seen revenue plummet as demand for this flagship product -- Moderna's first to be approved -- has slipped. As a result, the stock fell out of favor with investors, leading to a decline of about 80% over the past three years. Since that time, the biotech company has delivered positive news, from the approval of a second product -- its respiratory syncytial virus (RSV) vaccine -- to the approval of updated coronavirus vaccines and progress on cost cuts. Moderna also has an impressive late-stage pipeline and goals for potential product launches on the horizon. Yet none of these elements has been enough to pull the stock out of the doldrums. Considering this, is it time to dump your shares of Moderna? Let's find out. First, let's back up a bit and take a look at the Moderna story, from the glory days of a few years ago to its troubles today. As mentioned, Moderna sprang to the forefront in 2021 to 2022, bringing its messenger RNA vaccine candidate to market and generating billions of dollars in revenue and profit. Meanwhile, the biotech continued to apply this mRNA technology across its pipeline, advancing candidates for latent viruses such as cytomegalovirus (CMV), and making progress in the area of cancer vaccines. And these are just a couple of the company's late-stage programs. But investors focused primarily on Moderna's coronavirus vaccine, which at its peak in 2022 brought in a mind-boggling $18.4 billion in annual revenue. More recently, though, demand for coronavirus vaccination dropped, and Moderna's RSV vaccine delivered lackluster sales during its first "season" on the market -- respiratory vaccines generally see most uptake later in the year, during the cold and flu season. Moderna has progressively cut costs and refocused resources to support its goals of bringing many vaccines to market -- across multiple treatment areas -- over the next several years. In its most recent earnings report, the biotech said it expects to reduce GAAP operating costs by between $1.4 billion and $1.7 billion by 2027. The company continues to aim for as many as 10 product approvals within the next few years. And this includes "multiple" cancer vaccines, it says -- this is an area that Moderna has prioritized. Its pipeline currently has seven cancer-vaccine candidates -- for a range of indications including melanoma and bladder cancer -- in phase 2 or phase 3 studies. The product-approval goal, even if only partially reached this decade, could be a game changer for Moderna, offering it multiple revenue streams -- and eventually sources of revenue at blockbuster levels. However, as I said earlier, these positive points haven't yet led to lasting gains for the stock. Does this mean it's time to dump your Moderna shares? First, it's important to note that Moderna's difficult times may not be over. Investors continue to focus on the decline in coronavirus vaccine sales, and to a lesser degree, the early disappointment in the RSV market. And this subject takes the spotlight as each new flu season rolls around. On top of this, uncertainty about the Trump Administration's vaccine policies may prove to be a headwind. Most recently, Health and Human Services secretary Robert F. Kennedy Jr. let go a full panel of advisors who guide the government's vaccine decisions, saying that he would appoint new panel members. These issues could continue to weigh on Moderna's stock performance. But even considering this, and the fact that its pipeline hasn't yet pushed it onto investors' buy lists, I still wouldn't dump shares of Moderna right now. Why? Because the company has what it takes to succeed from a product and earnings angle, as I mentioned above. Often investors reward this ahead of time by piling into a stock as a company announces long-term prospects, but in Moderna's case, investors haven't followed that pattern. But eventually, as Moderna approaches the product-approval finish line with key candidates, including those in the field of oncology, the revenue picture may brighten significantly. If it does, the stock could finally soar. That's why long-term investors should hold on through the tough times and get ready for Moderna's next wave of growth -- even if it takes a while for the biotech to get there. Ever feel like you missed the boat in buying the most successful stocks? Then you'll want to hear this. On rare occasions, our expert team of analysts issues a 'Double Down' stock recommendation for companies that they think are about to pop. If you're worried you've already missed your chance to invest, now is the best time to buy before it's too late. And the numbers speak for themselves: Nvidia: if you invested $1,000 when we doubled down in 2009, you'd have $373,325!* Apple: if you invested $1,000 when we doubled down in 2008, you'd have $38,475!* Netflix: if you invested $1,000 when we doubled down in 2004, you'd have $649,102!* Right now, we're issuing 'Double Down' alerts for three incredible companies, available when you join , and there may not be another chance like this anytime soon.*Stock Advisor returns as of June 9, 2025 Adria Cimino has no position in any of the stocks mentioned. The Motley Fool recommends Moderna. The Motley Fool has a disclosure policy. Is it Time to Dump Your Shares of Moderna? was originally published by The Motley Fool
Yahoo
06-06-2025
- Automotive
- Yahoo
How to keep DQ files audit-ready
Qualifying drivers requires navigating complex Federal Motor Carrier Safety Regulations (FMCSRs). Doing this correctly is critical, as non-compliant driver qualification files can result in substantial audit fines and serve as a basis for negligence claims in post-crash litigation. Maintaining audit-ready DQ files isn't just about regulatory compliance—it's essential for protecting your business from financial and reputational damage. Since COVID restrictions have been lifted, FMCSA has prioritized face-to-face audits. After almost two years of increased remote evaluations, on-site screenings have skyrocketed. These comprehensive audits have more than doubled, jumping from nearly 2,000 in 2020 to over 4,400 in 2024. Additionally, FMCSA has increased record-keeping penalties to $1,544 per day, with a maximum penalty of $15,445. This shift is important for carriers to be aware of, as onsite audits are typically more thorough and detailed. Some violations detected during audits are so severe that even a single instance requires immediate corrective action. According to FMCSA's Analysis and Information Online, the most common acute violations regarding driver qualification include: Using a driver with a suspended CDL, disqualified status or multiple CDLs Allowing a driver with more than one CDL to operate a CMV Driving a CMV while disqualified Using an unqualified driver showing as Prohibited on the MVR Using a physically unqualified driver While these acute violations require immediate and specific action, critical violations represent broader issues with the company's recordkeeping and compliance efforts. These violations can add up to create liability issues and downgraded safety ratings. Common critical violations include: Driver applications that are missing, incomplete or non-compliant Lacking documentation of safety performance history from all DOT-regulated employers from the previous three years Motor vehicle records (MVRs) showing drivers not properly licensed for assigned vehicles (wrong class, missing endorsements, restricted/suspended/revoked licenses) When accidents happen, plaintiff attorneys will immediately look into the involved company's safety record. Hiring drivers with questionable safety histories or failing to follow FMCSRs will become the focus of litigation, stacking the deck against the carrier. In order to avoid this outcome, carriers must fulfill their duty to employ qualified and safe drivers. The American Transportation Research Institute's 2022 study, 'Understanding the Impact of Nuclear Verdicts on the Trucking Industry,' found that both defense and plaintiffs' attorneys agree on three key factors for protecting carriers from nuclear verdicts: Crash avoidance is paramount, meeting and exceeding regulations is essential and strict adherence to company policies is critical. 'Don't make it easy for plaintiff's attorneys. They are experts in every aspect of DQ files or they hire experts to find inconsistent execution of policies or blatant non-compliance. Carriers need their own experts to stay defendable,' says Mark Schedler, J. J. Keller's Senior Editor of Transport Management. Headline-making crashes can severely damage a company's reputation and ability to secure future business. Details about what contributed to a crash often become public knowledge. Media coverage of poor hiring practices can result in customers losing trust and wanting to avoid vicarious liability, including being sued because of a carrier's crash while hauling their goods. A comprehensive DQ Checklist should focus on keeping only FMCSA-required driver qualification documents in the file whenever possible. Files are easier to audit when they contain only necessary documentation. Non-required or 'nice to have' documents only add clutter and should be stored elsewhere with appropriate security protocols. 'Nice to have' documents include qualification checklists, documents certifying the driver agrees to follow certain rules, statements of on-duty time and training records for non-required training. While these documents may provide additional information, they should be stored separately from the official DQ file to maintain clarity and compliance focus. 'I am a backpacker with 25 plus years of experience who goes into the wilderness with everything I need to stay safe. I use a checklist for every trip, and I recommend that carriers do the same for every DQ file,' noted Schedler. This checklist created by J. J. Keller includes permanent FMCSA-required items for all drivers, recurring items and those applicable only to drivers operating vehicles requiring a CDL, as well as optional best practices. 'If you are looking at using a third-party expert, J. J. Keller's Managed Services team has an over 160-item checklist that they use to keep DQ files audit ready. That goes a long way to staying defendable,' according to Schedler. While FMCSA allows an acquiring company to accept DQ files from the acquired company, a company won't know what violations they are inheriting without conducting a full audit of these files. Missing or incomplete records could also lead to penalties or legal consequences. The acquiring company assumes responsibility for any deficiencies—even if the violations occurred under previous ownership. Being unaware of compliance gaps creates significant risk if an unqualified driver operates a CMV and becomes involved in a crash, regardless of fault. When moving employees from warehouse or other non-DOT regulated positions to CMV driving roles, companies often miss critical requirements like obtaining a DOT-compliant application per 391.21. These oversights can lead to serious violations and potential liability. Drivers with breaks in employment require new DQ files with updated documentation, though some existing documents may be reused. Carriers must accurately determine whether a driver is a rehire or simply returning from extended time off to ensure proper documentation is maintained. By understanding these common risk scenarios and implementing thorough checklist procedures, carriers can maintain audit-ready DQ files that not only satisfy regulatory requirements but also provide protection against costly fines, litigation and reputational damage. Investing in proper driver qualification management today prevents significant problems tomorrow. The post How to keep DQ files audit-ready appeared first on FreightWaves.
